Protalix BioTherapeutics
PLX
#8910
Rank
$0.14 B
Marketcap
$1.75
Share price
1.74%
Change (1 day)
7.36%
Change (1 year)

Protalix BioTherapeutics (PLX) - Net assets

Net assets on the balance sheet as of June 2025 : $49.9 Million USD

According to Protalix BioTherapeutics 's latest financial reports the company has $49.9 Million USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Protalix BioTherapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$$43.21 M28.72%
2023-12-31$$33.56 M-415.5%
2022-12-31$-$10.64 Million76.28%
2021-12-31$-$6.04 Million-77.68%
2020-12-31$-$27.04 Million-61.55%
2019-12-31$-$70.33 Million32.98%
2018-12-31$-$52.89 Million79.52%
2017-12-31$-$29.46 Million195.84%
2016-12-31$-$9.96 Million-191.58%
2015-12-31$$10.87 M-119.56%
2014-12-31$-$55.61 Million106.34%
2013-12-31$-$26.95 Million702.68%
2012-12-31$-$3.36 Million-87.13%
2011-12-31$-$26.08 Million130.3%
2010-12-31$-$11.33 Million-171.29%
2009-12-31$$15.88 M-64.18%
2008-12-31$$44.34 M-30.37%
2007-12-31$$63.68 M162.25%
2006-12-31$$24.28 M298.42%
2005-12-31$$6.09 M1131.31%
2004-12-31$$0.49 M-24.48%
2003-12-31$$0.65 M-17.67%
2002-12-31$$0.79 M-15.83%
2001-12-31$$0.94 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Amicus Therapeutics
FOLD
$0.23 B 361.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$3.00 B 5,918.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$93.09 B 186,453.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$7.25 B 14,436.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel